See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Apo-amitriptyline, Elatrol, Elavil, Endep, Laroxyl, Saroten, Sarotex, Tryptizol
What is Amitriptyline? Amitriptyline is a tricyclic antidepressant approved for the treatment of depression. Off label amitripyline is used for certain chronic and neuropathic (nerve) pain and for prevention of migraine headaches.
See more information, including instructions, precautions, side effects, and interactions.
176 patients in the community are taking or have taken Amitriptyline.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Pain | 51 | 28% |
| Other | 51 | 28% |
| Depression | 17 | 9% |
| Fatigue | 7 | 3% |
| Emotional lability | 5 | 2% |
| Anxiety | 5 | 2% |
| General health | 4 | 2% |
| Difficulty sleeping through night | 4 | 2% |
| Stiffness/spasticity | 3 | 1% |
| Don't know | 3 | 1% |
| Insomnia | 3 | 1% |
| Bladder problems | 2 | 1% |
| Sensation | 2 | 1% |
| Slow my MS progress | 2 | 1% |
| Sleep deprivation | 1 | <1% |
| Sleep problems | 1 | <1% |
| Irritability | 1 | <1% |
| Mood swings | 1 | <1% |
| Muscle twitching (fasciculations) | 1 | <1% |
| Headaches - Right eye/neck/head | 1 | <1% |
| Sleeplessness | 1 | <1% |
| disease-related symptoms | 1 | <1% |
| Neuropathy pain | 1 | <1% |
| Headaches/ Migraines | 1 | <1% |
| Burning sensation, legs | 1 | <1% |
| chronic daily headache | 1 | <1% |
How long current patients have been taking Amitriptyline or how long patients were taking Amitriptyline before stopping.
Results from 25 patient evaluations. See the overall results and all individual evaluations.
| Major | 45% | 5 |
|---|---|---|
| Moderate | 27% | 3 |
| Slight | 9% | 1 |
| None | 9% | 1 |
| Can't tell | 9% | 1 |
Other
| Severe | 16% | 4 |
|---|---|---|
| Moderate | 16% | 4 |
| Mild | 28% | 7 |
| None | 40% | 10 |
Top reported side-effects include: makes me groggy durning the day, dry mouth, "Hangover effect", next day
Summary results are based on 25 individual responses. For more information, see overall results for Adherence, Burden and Cost.